DISARM THERAPEUTICS INC has a total of 14 patent applications. Its first patent ever was published in 2019. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are GENESOFT PHARMACEUTICALS INC, HUA MEDICINE and PETRA PHARMA CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 3 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Special acyclic compounds | |
#4 | Peptides | |
#5 | Medical preparations | |
#6 | Climate change adaptation technologies | |
#7 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Devraj Rajesh | 14 |
#2 | Hughes Robert Owen | 14 |
#3 | Bosanac Todd | 14 |
#4 | Bentley Jonathan | 12 |
#5 | Jarjes-Pike Richard Andrew | 11 |
#6 | Brearley Andrew Simon | 11 |
#7 | Krauss Raul Eduardo | 2 |
#8 | Engber Thomas | 2 |
#9 | Brearley Andrew | 1 |
#10 | Parrott Shelley Anne | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021050913A1 | Inhibitors of sarm1 | |
WO2020252229A2 | Inhibitors of sarm1 | |
WO2020247701A2 | Inhibitors of sarm1 | |
WO2020132045A1 | Inhibitors of sarm1 in combination with neuroprotective agents | |
WO2020081923A1 | Inhibitors of sarm1 in combination with nad+ or a nad+ precursor | |
CA3108669A1 | Inhibitors of sarm1 | |
EP3801500A1 | Inhibitors of sarm1 | |
CA3102598A1 | Inhibitors of sarm1 |